The Global Injectable Benzodiazepines Industry is on the brink of a substantial transformation, with a projected Compound Annual Growth Rate (CAGR) of 2.7% from 2022 to 2032. According to market insights, sales of injectable benzodiazepines are expected to reach a remarkable US$ 356 million, reflecting the increasing demand for these critical pharmaceuticals in addressing escalating …